• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

iPSC 衍生的 PSEN2(N141I)星形胶质细胞和小胶质细胞表现出激活的炎症表型。

iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype.

机构信息

School of Medical Sciences, The Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.

School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, Camperdown, Australia.

出版信息

J Neuroinflammation. 2024 Jan 4;21(1):7. doi: 10.1186/s12974-023-02951-2.

DOI:10.1186/s12974-023-02951-2
PMID:38178159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10765839/
Abstract

BACKGROUND

Widescale evidence points to the involvement of glia and immune pathways in the progression of Alzheimer's disease (AD). AD-associated iPSC-derived glial cells show a diverse range of AD-related phenotypic states encompassing cytokine/chemokine release, phagocytosis and morphological profiles, but to date studies are limited to cells derived from PSEN1, APOE and APP mutations or sporadic patients. The aim of the current study was to successfully differentiate iPSC-derived microglia and astrocytes from patients harbouring an AD-causative PSEN2 (N141I) mutation and characterise the inflammatory and morphological profile of these cells.

METHODS

iPSCs from three healthy control individuals and three familial AD patients harbouring a heterozygous PSEN2 (N141I) mutation were used to derive astrocytes and microglia-like cells and cell identity and morphology were characterised through immunofluorescent microscopy. Cellular characterisation involved the stimulation of these cells by LPS and Aβ and analysis of cytokine/chemokine release was conducted through ELISAs and multi-cytokine arrays. The phagocytic capacity of these cells was then indexed by the uptake of fluorescently-labelled fibrillar Aβ.

RESULTS

AD-derived astrocytes and microglia-like cells exhibited an atrophied and less complex morphological appearance than healthy controls. AD-derived astrocytes showed increased basal expression of GFAP, S100β and increased secretion and phagocytosis of Aβ while AD-derived microglia-like cells showed decreased IL-8 secretion compared to healthy controls. Upon immunological challenge AD-derived astrocytes and microglia-like cells showed exaggerated secretion of the pro-inflammatory IL-6, CXCL1, ICAM-1 and IL-8 from astrocytes and IL-18 and MIF from microglia.

CONCLUSION

Our study showed, for the first time, the differentiation and characterisation of iPSC-derived astrocytes and microglia-like cells harbouring a PSEN2 (N141I) mutation. PSEN2 (N141I)-mutant astrocytes and microglia-like cells presented with a 'primed' phenotype characterised by reduced morphological complexity, exaggerated pro-inflammatory cytokine secretion and altered Aβ production and phagocytosis.

摘要

背景

大量证据表明神经胶质细胞和免疫途径参与了阿尔茨海默病(AD)的进展。与 AD 相关的 iPSC 衍生神经胶质细胞表现出多种与 AD 相关的表型状态,包括细胞因子/趋化因子释放、吞噬作用和形态学特征,但迄今为止的研究仅限于源自 PSEN1、APOE 和 APP 突变或散发性患者的细胞。本研究的目的是成功地从携带 AD 致病 PSEN2(N141I)突变的患者中分化 iPSC 衍生的小胶质细胞和星形胶质细胞,并描述这些细胞的炎症和形态特征。

方法

使用来自三个健康对照个体和三个携带杂合 PSEN2(N141I)突变的家族性 AD 患者的 iPSC 衍生星形胶质细胞和小胶质细胞样细胞,并通过免疫荧光显微镜对细胞特性和形态进行鉴定。细胞鉴定涉及 LPS 和 Aβ 对这些细胞的刺激,通过 ELISA 和多细胞因子阵列分析细胞因子/趋化因子的释放。然后通过荧光标记的纤维状 Aβ的摄取来评估这些细胞的吞噬能力。

结果

AD 衍生的星形胶质细胞和小胶质细胞样细胞表现出萎缩和形态复杂性降低的形态。AD 衍生的星形胶质细胞表现出 GFAP、S100β 的基础表达增加以及 Aβ 的分泌和吞噬增加,而 AD 衍生的小胶质细胞样细胞与健康对照组相比,IL-8 的分泌减少。在免疫挑战下,AD 衍生的星形胶质细胞和小胶质细胞样细胞表现出促炎细胞因子 IL-6、CXCL1、ICAM-1 和星形胶质细胞的 IL-8 以及小胶质细胞的 IL-18 和 MIF 的过度分泌。

结论

我们的研究首次显示了携带 PSEN2(N141I)突变的 iPSC 衍生星形胶质细胞和小胶质细胞样细胞的分化和特征。携带 PSEN2(N141I)突变的星形胶质细胞和小胶质细胞样细胞表现出“致敏”表型,其特征是形态复杂性降低、促炎细胞因子分泌过度以及 Aβ 产生和吞噬作用改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/1662556b4125/12974_2023_2951_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/7635aff92e1f/12974_2023_2951_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/eb9a4365ed30/12974_2023_2951_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/bc5a0ec16dbd/12974_2023_2951_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/f75e8355c12e/12974_2023_2951_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/2081e7c5c5fb/12974_2023_2951_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/ce3fc88448d1/12974_2023_2951_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/ef2fe4f48e06/12974_2023_2951_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/bf86ee0fd1eb/12974_2023_2951_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/7820ff6ee18c/12974_2023_2951_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/4288a9030139/12974_2023_2951_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/1662556b4125/12974_2023_2951_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/7635aff92e1f/12974_2023_2951_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/eb9a4365ed30/12974_2023_2951_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/bc5a0ec16dbd/12974_2023_2951_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/f75e8355c12e/12974_2023_2951_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/2081e7c5c5fb/12974_2023_2951_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/ce3fc88448d1/12974_2023_2951_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/ef2fe4f48e06/12974_2023_2951_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/bf86ee0fd1eb/12974_2023_2951_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/7820ff6ee18c/12974_2023_2951_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/4288a9030139/12974_2023_2951_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f23/10765839/1662556b4125/12974_2023_2951_Fig11_HTML.jpg

相似文献

1
iPSC-derived PSEN2 (N141I) astrocytes and microglia exhibit a primed inflammatory phenotype.iPSC 衍生的 PSEN2(N141I)星形胶质细胞和小胶质细胞表现出激活的炎症表型。
J Neuroinflammation. 2024 Jan 4;21(1):7. doi: 10.1186/s12974-023-02951-2.
2
Early-Onset Familial Alzheimer Disease Variant PSEN2 N141I Heterozygosity is Associated with Altered Microglia Phenotype.早发性家族性阿尔茨海默病变异 PSEN2 N141I 杂合性与小胶质细胞表型改变有关。
J Alzheimers Dis. 2020;77(2):675-688. doi: 10.3233/JAD-200492.
3
CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer's PSEN2 neurons.CRISPR/Cas9 校正相关突变的分子和生理表型在 iPSC 衍生的阿尔茨海默病 PSEN2 神经元中。
Acta Neuropathol Commun. 2017 Oct 27;5(1):77. doi: 10.1186/s40478-017-0475-z.
4
iPSC-derived familial Alzheimer's PSEN2 cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling.iPSC 衍生的家族性阿尔茨海默病 PSEN2 胆碱能神经元表现出突变依赖性分子病理学,该病理学可被胰岛素信号纠正。
Mol Neurodegener. 2018 Jun 26;13(1):33. doi: 10.1186/s13024-018-0265-5.
5
Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro.携带 PSEN1 或 PSEN2 基因突变与体外脑内皮细胞表型受损有关。
Fluids Barriers CNS. 2021 Jan 7;18(1):3. doi: 10.1186/s12987-020-00235-y.
6
APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types.载脂蛋白 E4 导致与人类 iPSC 衍生脑细胞类型的阿尔茨海默病表型相关的广泛分子和细胞改变。
Neuron. 2018 Jun 27;98(6):1141-1154.e7. doi: 10.1016/j.neuron.2018.05.008. Epub 2018 May 31.
7
Lipid-polymer hybrid nanoparticles loaded with -acetylcysteine for the modulation of neuroinflammatory biomarkers in human iPSC-derived PSEN2 (N141I) astrocytes as a model of Alzheimer's disease.负载有N-乙酰半胱氨酸的脂质-聚合物杂化纳米颗粒用于调节人诱导多能干细胞衍生的PSEN2(N141I)星形胶质细胞中的神经炎症生物标志物,以此作为阿尔茨海默病的模型。
J Mater Chem B. 2024 May 29;12(21):5085-5097. doi: 10.1039/d4tb00521j.
8
Generation of gene edited hiPSC from familial Alzheimer's disease patient carrying N141I missense mutation in presenilin 2.从携带早老素 2 N141I 错义突变的家族性阿尔茨海默病患者中生成基因编辑的 hiPSC。
Stem Cell Res. 2021 Oct;56:102552. doi: 10.1016/j.scr.2021.102552. Epub 2021 Oct 7.
9
Cardiolipin released by microglia can act on neighboring glial cells to facilitate the uptake of amyloid-β (1-42).小胶质细胞释放的心磷脂可作用于邻近的神经胶质细胞,以促进β淀粉样蛋白(1-42)的摄取。
Mol Cell Neurosci. 2023 Mar;124:103804. doi: 10.1016/j.mcn.2022.103804. Epub 2022 Dec 30.
10
Cerebral organoids derived from patients with Alzheimer's disease with PSEN1/2 mutations have defective tissue patterning and altered development.源自阿尔茨海默病伴 PSEN1/2 突变患者的脑类器官具有组织形态缺陷和发育异常。
Cell Rep. 2023 Nov 28;42(11):113310. doi: 10.1016/j.celrep.2023.113310. Epub 2023 Oct 20.

引用本文的文献

1
Induced Microglial-like Cells Derived from Familial and Sporadic Alzheimer's Disease Peripheral Blood Monocytes Show Abnormal Phagocytosis and Inflammatory Response to PSEN1 E280A Cholinergic-like Neurons.源自家族性和散发性阿尔茨海默病外周血单核细胞的诱导性小胶质细胞样细胞对PSEN1 E280A胆碱能样神经元表现出异常吞噬作用和炎症反应。
Int J Mol Sci. 2025 Jul 24;26(15):7162. doi: 10.3390/ijms26157162.
2
In reply to Letter to the Editor from Paudel: Comment on "Changes in iPSC-Astrocyte Morphology Reflect Alzheimer's Disease Patient Clinical Markers".回复保德尔致编辑的信:对“诱导多能干细胞来源的星形胶质细胞形态变化反映阿尔茨海默病患者临床标志物”的评论。
Stem Cells. 2025 Jun 24;43(7). doi: 10.1093/stmcls/sxaf031.
3

本文引用的文献

1
Presenilin 2 N141I mutation induces hyperactive immune response through the epigenetic repression of REV-ERBα.早老素 2 N141I 突变通过表观遗传抑制 REV-ERBα 诱导过度活跃的免疫反应。
Nat Commun. 2022 Apr 13;13(1):1972. doi: 10.1038/s41467-022-29653-2.
2
Astrocytic C-X-C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity.星形细胞 C-X-C 基序趋化因子配体-1 介导β-淀粉样蛋白诱导的突触毒性。
J Neuroinflammation. 2021 Dec 28;18(1):306. doi: 10.1186/s12974-021-02371-0.
3
Microglial morphology in Alzheimer's disease and after Aβ immunotherapy.
Induced Pluripotent Stem Cells-Based Regenerative Therapies in Treating Human Aging-Related Functional Decline and Diseases.
基于诱导多能干细胞的再生疗法治疗人类衰老相关功能衰退和疾病
Cells. 2025 Apr 21;14(8):619. doi: 10.3390/cells14080619.
4
Efficient derivation of functional astrocytes from human induced pluripotent stem cells (hiPSCs).从人诱导多能干细胞(hiPSC)高效衍生功能性星形胶质细胞。
PLoS One. 2024 Dec 4;19(12):e0313514. doi: 10.1371/journal.pone.0313514. eCollection 2024.
5
Dynamic neuroinflammatory profiles predict Alzheimer's disease pathology in microglia-containing cerebral organoids.动态神经炎症特征可预测含小胶质细胞的脑类器官中的阿尔茨海默病病理。
bioRxiv. 2024 Apr 3:2023.11.16.567220. doi: 10.1101/2023.11.16.567220.
阿尔茨海默病及 Aβ 免疫治疗后小胶质细胞形态。
Sci Rep. 2021 Aug 5;11(1):15955. doi: 10.1038/s41598-021-95535-0.
4
Classification of Microglial Morphological Phenotypes Using Machine Learning.使用机器学习对小胶质细胞形态表型进行分类
Front Cell Neurosci. 2021 Jun 29;15:701673. doi: 10.3389/fncel.2021.701673. eCollection 2021.
5
Tubular human brain organoids to model microglia-mediated neuroinflammation.人脑组织类器官模型中小胶质细胞介导的神经炎症。
Lab Chip. 2021 Jul 13;21(14):2751-2762. doi: 10.1039/d1lc00030f.
6
Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia.阿尔茨海默病风险基因TREM2决定新型人诱导多能干细胞衍生小胶质细胞的功能特性。
Front Immunol. 2021 Feb 3;11:617860. doi: 10.3389/fimmu.2020.617860. eCollection 2020.
7
Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer's disease.人类多能干细胞来源的小胶质细胞的完全定义和阿尔茨海默病中 C3 产生的三细胞培养系统模型。
Nat Neurosci. 2021 Mar;24(3):343-354. doi: 10.1038/s41593-020-00796-z. Epub 2021 Feb 8.
8
TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages.TREM2 阿尔茨海默病变异体 R47H 引起类似的转录失调与敲除相当,但在人诱导多能干细胞衍生的巨噬细胞中仅有细微的功能表型。
Alzheimers Res Ther. 2020 Nov 16;12(1):151. doi: 10.1186/s13195-020-00709-z.
9
Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease.基因表达和功能缺陷是阿尔茨海默病人类模型中 TREM2 敲除小胶质细胞反应的基础。
Nat Commun. 2020 Oct 23;11(1):5370. doi: 10.1038/s41467-020-19227-5.
10
Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions.Trem2 促进小胶质细胞的抗炎反应,并在促炎条件下受到抑制。
Hum Mol Genet. 2020 Nov 25;29(19):3224-3248. doi: 10.1093/hmg/ddaa209.